🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study of a drug drug interaction between Supaglutide and Digoxin ...
Status
Completed
Location
Huashan Hospital, Fudan University
Start Date
2023-03-20
Trial ID
NCT05694221
Treatments Being Tested
This is a multiple part, multiple cohort study evaluating single and multip...
Status
Completed
Location
Celerion
Start Date
2024-11-30
Trial ID
NCT06717269
Treatments Being Tested
The primary objective of the study is to reduce hospital admission and decr...
Status
Completed
Location
Matthew Hysell
Start Date
2020-06-19
Trial ID
NCT05391893
Treatments Being Tested
The purpose of this study is to evaluate the effect of repeated-dose admini...
Status
Completed
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02370615
Treatments Being Tested
Non-medullary thyroid carcinoma has a good prognosis in most patients. Howe...
Status
Completed
Location
Radboud University Medical Center
Start Date
2022-12-06
Trial ID
NCT05507775
Treatments Being Tested
The purpose of this study is to investigate the effect of steady-state (con...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01519128
Treatments Being Tested
The drug-drug interaction study had been designed to investigate the effect...
Status
Active Not Recruiting
Location
Dongguan People's Hospital
Start Date
2025-04-14
Trial ID
NCT07362030
Treatments Being Tested
Apatinib, an oral inhibitor of vascular endothelial growth factor receptor ...
Status
Completed
Location
Hunan Cancer Hospital
Start Date
2020-03-12
Trial ID
NCT04322552
Treatments Being Tested
The primary objectives of this study are the following: * To evaluate the ...
Status
Completed
Location
PPD
Start Date
2019-03-11
Trial ID
NCT03856970
Treatments Being Tested
The aim of this trial is to assess the potential key drug-drug interactions...
Status
Completed
Location
Clinical Trial Consultants AB
Start Date
2023-10-23
Trial ID
NCT06118684
Treatments Being Tested